Article Details

Neurocrine Biosciences (NASDAQ:NBIX) Downgraded by Zacks Investment Research

Retrieved on: 2021-04-11 04:41:15

Tags for this article:

Click the tags to see associated articles and topics

Neurocrine Biosciences (NASDAQ:NBIX) Downgraded by Zacks Investment Research. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 49,124 shares of the company's stock worth $4,724,000 after buying an additional 957 shares during the last ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up